Results 91 to 100 of about 94,533 (302)

Lipid Nanoparticles for Delivery of CRISPR Gene Editing Components

Small Methods, EarlyView.
The review presents a comprehensive overview of each component of lipid nanoparticles（LNPs）and their effects on editing efficiency. It specifically highlights strategies for achieving non‐liver delivery, aiming for broader applications in gene editing. Furthermore, this review summarizes the applications of LNPs in gene editing and offers insights for ...
Fan Wu, Nei Li, Yudian Xiao, Rohan Palanki, Hannah Yamagata, Michael J. Mitchell, Xuexiang Han   +6 more
wiley   +1 more source

Hydrogel-Delivered GM-CSF Overcomes Nonresponsiveness to Hepatitis B Vaccine through the Recruitment and Activation of Dendritic Cells [PDF]

, 2010
Ho-Yuan Chou, Xi-Zhang Lin, Wen-Yu Pan, Ping-Yi Wu, Chia‐Ming Chang, Tsai‐Yu Lin, Hsin-Hsin Shen, Mi‐Hua Tao   +7 more
openalex   +1 more source

The Power of Yeast

Yeast, EarlyView.
ABSTRACT Yeasts have been intimately connected with human civilization for millennia, originally used for fermentation in food and beverage production. This article explores the multifaceted roles of yeasts—particularly Saccharomyces cerevisiae—as both a model organism and a cell factory.
Jens Nielsen
wiley   +1 more source

Distinct 5′ UTR Requirements for Translation of the Bicistronic X/P mRNA Among Avian Orthobornaviruses

Microbiology and Immunology, EarlyView.
ABSTRACT Orthobornaviruses express X and the phosphoprotein (P) from a bicistronic X/P mRNA, and these proteins regulate polymerase activity. In mammalian orthobornaviruses, the 5′ untranslated region (5′ UTR) of the X/P mRNA controls the translational balance between X and P and thereby promotes efficient replication.
Meng‐Chi Wu, Takehiro Kanda, Ryo Komorizono, Madoka Sakai, Alexander Leacy, Leonardo Susta, Akiko Makino, Keizo Tomonaga   +7 more
wiley   +1 more source

Hepatitis B vaccine in infants: a randomized controlled trial comparing gluteal versus anterolateral thigh muscle administration

Revista do Instituto de Medicina Tropical de São Paulo, 2001
A significantly diminished antibody response to hepatitis B vaccine has been demonstrated in adults when the buttock is used as the injection site.
Andrea Santos Rafael ALVES, Cristiane M.R. NASCIMENTO, Celso H. GRANATO, Helena Keiko SATO, Marina F. MORGATO, Claudio S. PANNUTI   +5 more
doaj  

Predictors of Hepatitis B Virus Infection Vaccine Hesitancy Among Pregnant Women Attending Antenatal Care at Lubaga Hospital, Kampala, Uganda

, 2022
Ismail Bamidele Afolabi, Abdulmujeeb Babatunde Aremu, Lawal Abdurraheem Maidoki, Nnodimele Onuigbo Atulomah   +3 more
openalex   +2 more sources

Live Zoster Vaccination and the Reduced Risk of Chronic Respiratory Diseases: An Emulated Target Trial

Allergy, EarlyView.
This emulated target trial investigated the risk of developing chronic respiratory diseases (COPD, asthma, and ILD) associated with live zoster vaccination using a nationwide, population‐based cohort of individuals aged ≥ 50 years in South Korea. Live zoster vaccination significantly reduced the risk of COPD, asthma, and ILD, and reduced hospital ...
Tae Hyeon Kim, Kyeongmin Lee, Jaehyeong Cho, Jiyeon Oh, Sooji Lee, Lee Smith, Francesco Branda, Junyang Jung, Jinseok Lee, Hayeon Lee, Dong Keon Yon   +10 more
wiley   +1 more source

On the future of therapeutic vaccination in chronic hepatitis B

Future Science OA, 2019
Julio Cesar Aguilar Rubido
doaj   +1 more source

Prediction of Response to Hepatitis B Vaccine in Health Care Workers: Whose Titers of Antibody to Hepatitis B Surface Antigen Should Be Determined After a Three‐Dose Series, and What Are the Implications in Terms of Cost‐Effectiveness? [PDF]

, 1998
Kaliroi Alimonos, Anne N. Nafziger, James L. Murray, Joseph Bertino   +3 more
openalex   +1 more source

Meta‐Analysis: High anti‐HBs Titers are Associated with Significantly Reduced Risk of Hepatitis B Virus Reactivation During Rituximab Treatment

Alimentary Pharmacology &Therapeutics, EarlyView.
This meta‐analysis demonstrates a significantly lower risk for HBV reactivation on rituximab if anti‐HBs is > 100 iU/L (3.5%, CI: 1.8%–6.9%) vs. anti‐HBs between 10 and 100 iU/L (13.8%, CI: 8.8%–20.8%) and anti‐HBs negative (27.3%, CI: 20.0%–36.0%). Thus, if anti‐HBs titer is > 10 iU/L, monitoring could be considered.
Shiva Poola, MaryKate Kratzer, Kerry Sewell, Zikun Yang, Hans L. Tillmann   +4 more
wiley   +1 more source